▶ 調査レポート

尋常性痤瘡の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Acne Vulgaris Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。尋常性痤瘡の世界市場2020年:企業別、地域別、種類・用途別 / Global Acne Vulgaris Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0GIR-02727資料のイメージです。• レポートコード:D0GIR-02727
• 出版社/出版日:GlobalInfoResearch / 2020年9月30日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、尋常性痤瘡の世界市場を広く調査・分析し、今後の市場展望をまとめております。尋常性痤瘡の種類別市場規模(全身療法、調和療法、理学療法、局所併用療法、その他)、用途別市場規模(病院・クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Allergan、Vyome Bioscience、Hygeia Laboratories、Bayer、Novan、Cipher、Bausch Health、Johnson & Johnson
・地域別グローバル市場分析 2015年-2020年
・尋常性痤瘡の北米市場(アメリカ、カナダ、メキシコ)
・尋常性痤瘡のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・尋常性痤瘡のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・尋常性痤瘡の南米市場(ブラジル、アルゼンチン)
・尋常性痤瘡の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:全身療法、調和療法、理学療法、局所併用療法、その他
・用途別分析:病院・クリニック、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Acne Vulgaris market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Acne Vulgaris market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Acne Vulgaris market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Acne Vulgaris market has been segmented into:
Systemic Therapy
Harmonal Therapy
Physical Treatment
Topical Combination Therapy
Others

By Application, Acne Vulgaris has been segmented into:
Hospitals and Clinics
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acne Vulgaris market presented in the report. This section sheds light on the sales growth of different regional and country-level Acne Vulgaris markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acne Vulgaris market.

The report offers in-depth assessment of the growth and other aspects of the Acne Vulgaris market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Acne Vulgaris Market Share Analysis
Acne Vulgaris competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acne Vulgaris sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acne Vulgaris sales, revenue and market share for each player covered in this report.

The major players covered in Acne Vulgaris are:
Allergan
Vyome Bioscience
Hygeia Laboratories
Bayer
Novan
Cipher
Bausch Health
Johnson & Johnson

レポート目次

Table of Contents

1 Acne Vulgaris Market Overview
1.1 Product Overview and Scope of Acne Vulgaris
1.2 Classification of Acne Vulgaris by Type
1.2.1 Global Acne Vulgaris Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Acne Vulgaris Revenue Market Share by Type in 2019
1.2.3 Systemic Therapy
1.2.4 Harmonal Therapy
1.2.5 Physical Treatment
1.2.6 Topical Combination Therapy
1.2.7 Others
1.3 Global Acne Vulgaris Market by Application
1.3.1 Overview: Global Acne Vulgaris Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Acne Vulgaris Market by Regions
1.4.1 Global Acne Vulgaris Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Acne Vulgaris (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Acne Vulgaris Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Acne Vulgaris Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acne Vulgaris Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Acne Vulgaris Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acne Vulgaris Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Acne Vulgaris Revenue, Gross Margin and Market Share (2018-2019)
2.2 Vyome Bioscience
2.2.1 Vyome Bioscience Details
2.2.2 Vyome Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Vyome Bioscience SWOT Analysis
2.2.4 Vyome Bioscience Product and Services
2.2.5 Vyome Bioscience Acne Vulgaris Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hygeia Laboratories
2.3.1 Hygeia Laboratories Details
2.3.2 Hygeia Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hygeia Laboratories SWOT Analysis
2.3.4 Hygeia Laboratories Product and Services
2.3.5 Hygeia Laboratories Acne Vulgaris Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Acne Vulgaris Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novan
2.5.1 Novan Details
2.5.2 Novan Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novan SWOT Analysis
2.5.4 Novan Product and Services
2.5.5 Novan Acne Vulgaris Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cipher
2.6.1 Cipher Details
2.6.2 Cipher Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cipher SWOT Analysis
2.6.4 Cipher Product and Services
2.6.5 Cipher Acne Vulgaris Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bausch Health
2.7.1 Bausch Health Details
2.7.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bausch Health SWOT Analysis
2.7.4 Bausch Health Product and Services
2.7.5 Bausch Health Acne Vulgaris Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson & Johnson SWOT Analysis
2.8.4 Johnson & Johnson Product and Services
2.8.5 Johnson & Johnson Acne Vulgaris Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Acne Vulgaris Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Acne Vulgaris Players Market Share
3.2.2 Top 10 Acne Vulgaris Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Acne Vulgaris Revenue and Market Share by Regions
4.2 North America Acne Vulgaris Revenue and Growth Rate (2015-2020)
4.3 Europe Acne Vulgaris Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Acne Vulgaris Revenue and Growth Rate (2015-2020)
4.5 South America Acne Vulgaris Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Acne Vulgaris Revenue and Growth Rate (2015-2020)
5 North America Acne Vulgaris Revenue by Countries
5.1 North America Acne Vulgaris Revenue by Countries (2015-2020)
5.2 USA Acne Vulgaris Revenue and Growth Rate (2015-2020)
5.3 Canada Acne Vulgaris Revenue and Growth Rate (2015-2020)
5.4 Mexico Acne Vulgaris Revenue and Growth Rate (2015-2020)
6 Europe Acne Vulgaris Revenue by Countries
6.1 Europe Acne Vulgaris Revenue by Countries (2015-2020)
6.2 Germany Acne Vulgaris Revenue and Growth Rate (2015-2020)
6.3 UK Acne Vulgaris Revenue and Growth Rate (2015-2020)
6.4 France Acne Vulgaris Revenue and Growth Rate (2015-2020)
6.5 Russia Acne Vulgaris Revenue and Growth Rate (2015-2020)
6.6 Italy Acne Vulgaris Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Acne Vulgaris Revenue by Countries
7.1 Asia-Pacific Acne Vulgaris Revenue by Countries (2015-2020)
7.2 China Acne Vulgaris Revenue and Growth Rate (2015-2020)
7.3 Japan Acne Vulgaris Revenue and Growth Rate (2015-2020)
7.4 Korea Acne Vulgaris Revenue and Growth Rate (2015-2020)
7.5 India Acne Vulgaris Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Acne Vulgaris Revenue and Growth Rate (2015-2020)
8 South America Acne Vulgaris Revenue by Countries
8.1 South America Acne Vulgaris Revenue by Countries (2015-2020)
8.2 Brazil Acne Vulgaris Revenue and Growth Rate (2015-2020)
8.3 Argentina Acne Vulgaris Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Acne Vulgaris by Countries
9.1 Middle East & Africa Acne Vulgaris Revenue by Countries (2015-2020)
9.2 Saudi Arabia Acne Vulgaris Revenue and Growth Rate (2015-2020)
9.3 UAE Acne Vulgaris Revenue and Growth Rate (2015-2020)
9.4 Egypt Acne Vulgaris Revenue and Growth Rate (2015-2020)
9.5 South Africa Acne Vulgaris Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Acne Vulgaris Revenue and Market Share by Type (2015-2020)
10.2 Global Acne Vulgaris Market Forecast by Type (2019-2024)
10.3 Systemic Therapy Revenue Growth Rate (2015-2025)
10.4 Harmonal Therapy Revenue Growth Rate (2015-2025)
10.5 Physical Treatment Revenue Growth Rate (2015-2025)
10.6 Topical Combination Therapy Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Acne Vulgaris Market Segment by Application
11.1 Global Acne Vulgaris Revenue Market Share by Application (2015-2020)
11.2 Acne Vulgaris Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Acne Vulgaris Market Size Forecast (2021-2025)
12.1 Global Acne Vulgaris Market Size Forecast (2021-2025)
12.2 Global Acne Vulgaris Market Forecast by Regions (2021-2025)
12.3 North America Acne Vulgaris Revenue Market Forecast (2021-2025)
12.4 Europe Acne Vulgaris Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Acne Vulgaris Revenue Market Forecast (2021-2025)
12.6 South America Acne Vulgaris Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Acne Vulgaris Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Acne Vulgaris Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Acne Vulgaris by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Acne Vulgaris Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Acne Vulgaris Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Allergan Corporate Information, Location and Competitors
Table 6. Allergan Acne Vulgaris Major Business
Table 7. Allergan Acne Vulgaris Total Revenue (USD Million) (2017-2018)
Table 8. Allergan SWOT Analysis
Table 9. Allergan Acne Vulgaris Product and Solutions
Table 10. Allergan Acne Vulgaris Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Vyome Bioscience Corporate Information, Location and Competitors
Table 12. Vyome Bioscience Acne Vulgaris Major Business
Table 13. Vyome Bioscience Acne Vulgaris Total Revenue (USD Million) (2018-2019)
Table 14. Vyome Bioscience SWOT Analysis
Table 15. Vyome Bioscience Acne Vulgaris Product and Solutions
Table 16. Vyome Bioscience Acne Vulgaris Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Hygeia Laboratories Corporate Information, Location and Competitors
Table 18. Hygeia Laboratories Acne Vulgaris Major Business
Table 19. Hygeia Laboratories Acne Vulgaris Total Revenue (USD Million) (2017-2018)
Table 20. Hygeia Laboratories SWOT Analysis
Table 21. Hygeia Laboratories Acne Vulgaris Product and Solutions
Table 22. Hygeia Laboratories Acne Vulgaris Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer Corporate Information, Location and Competitors
Table 24. Bayer Acne Vulgaris Major Business
Table 25. Bayer Acne Vulgaris Total Revenue (USD Million) (2017-2018)
Table 26. Bayer SWOT Analysis
Table 27. Bayer Acne Vulgaris Product and Solutions
Table 28. Bayer Acne Vulgaris Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novan Corporate Information, Location and Competitors
Table 30. Novan Acne Vulgaris Major Business
Table 31. Novan Acne Vulgaris Total Revenue (USD Million) (2017-2018)
Table 32. Novan SWOT Analysis
Table 33. Novan Acne Vulgaris Product and Solutions
Table 34. Novan Acne Vulgaris Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Cipher Corporate Information, Location and Competitors
Table 36. Cipher Acne Vulgaris Major Business
Table 37. Cipher Acne Vulgaris Total Revenue (USD Million) (2017-2018)
Table 38. Cipher SWOT Analysis
Table 39. Cipher Acne Vulgaris Product and Solutions
Table 40. Cipher Acne Vulgaris Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bausch Health Corporate Information, Location and Competitors
Table 42. Bausch Health Acne Vulgaris Major Business
Table 43. Bausch Health Acne Vulgaris Total Revenue (USD Million) (2017-2018)
Table 44. Bausch Health SWOT Analysis
Table 45. Bausch Health Acne Vulgaris Product and Solutions
Table 46. Bausch Health Acne Vulgaris Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Johnson & Johnson Corporate Information, Location and Competitors
Table 48. Johnson & Johnson Acne Vulgaris Major Business
Table 49. Johnson & Johnson Acne Vulgaris Total Revenue (USD Million) (2017-2018)
Table 50. Johnson & Johnson SWOT Analysis
Table 51. Johnson & Johnson Acne Vulgaris Product and Solutions
Table 52. Johnson & Johnson Acne Vulgaris Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Acne Vulgaris Revenue (Million USD) by Players (2015-2020)
Table 54. Global Acne Vulgaris Revenue Share by Players (2015-2020)
Table 55. Global Acne Vulgaris Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Acne Vulgaris Revenue Market Share by Regions (2015-2020)
Table 57. North America Acne Vulgaris Revenue by Countries (2015-2020)
Table 58. North America Acne Vulgaris Revenue Market Share by Countries (2015-2020)
Table 59. Europe Acne Vulgaris Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Acne Vulgaris Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Acne Vulgaris Revenue by Countries (2015-2020)
Table 62. South America Acne Vulgaris Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Acne Vulgaris Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Acne Vulgaris Revenue Market Share by Countries (2015-2020)
Table 65. Global Acne Vulgaris Revenue (Million USD) by Type (2015-2020)
Table 66. Global Acne Vulgaris Revenue Share by Type (2015-2020)
Table 67. Global Acne Vulgaris Revenue Forecast by Type (2021-2025)
Table 68. Global Acne Vulgaris Revenue by Application (2015-2020)
Table 69. Global Acne Vulgaris Revenue Share by Application (2015-2020)
Table 70. Global Acne Vulgaris Revenue Forecast by Application (2021-2025)
Table 71. Global Acne Vulgaris Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Acne Vulgaris Picture
Figure 2. Global Acne Vulgaris Revenue Market Share by Type in 2019
Figure 3. Systemic Therapy Picture
Figure 4. Harmonal Therapy Picture
Figure 5. Physical Treatment Picture
Figure 6. Topical Combination Therapy Picture
Figure 7. Others Picture
Figure 8. Acne Vulgaris Revenue Market Share by Application in 2019
Figure 9. Hospitals and Clinics Picture
Figure 10. Others Picture
Figure 11. Global Acne Vulgaris Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Acne Vulgaris Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Acne Vulgaris Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Acne Vulgaris Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Acne Vulgaris Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Acne Vulgaris Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Acne Vulgaris Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Acne Vulgaris Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Acne Vulgaris Revenue Market Share in 2019
Figure 20. Global Top 10 Players Acne Vulgaris Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Acne Vulgaris Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Acne Vulgaris Revenue Market Share by Regions (2015-2020)
Figure 24. Global Acne Vulgaris Revenue Market Share by Regions in 2018
Figure 25. North America Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 26. Europe Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 28. South America Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 30. North America Acne Vulgaris Revenue Market Share by Countries (2015-2020)
Figure 31. North America Acne Vulgaris Revenue Market Share by Countries in 2019
Figure 32. USA Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 33. Canada Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 35. Europe Acne Vulgaris Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Acne Vulgaris Revenue Market Share by Countries in 2019
Figure 37. Germany Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 38. UK Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 39. France Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 40. Russia Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 41. Italy Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Acne Vulgaris Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Acne Vulgaris Revenue Market Share by Countries in 2019
Figure 44. China Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 45. Japan Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 46. Korea Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 47. India Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 49. South America Acne Vulgaris Revenue Market Share by Countries (2015-2020)
Figure 50. South America Acne Vulgaris Revenue Market Share by Countries in 2019
Figure 51. Brazil Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Acne Vulgaris Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Acne Vulgaris Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 56. UAE Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Acne Vulgaris Revenue and Growth Rate (2015-2020)
Figure 59. Global Acne Vulgaris Revenue Share by Type (2015-2020)
Figure 60. Global Acne Vulgaris Revenue Share by Type in 2019
Figure 61. Global Acne Vulgaris Market Share Forecast by Type (2021-2025)
Figure 62. Global Systemic Therapy Revenue Growth Rate (2015-2020)
Figure 63. Global Harmonal Therapy Revenue Growth Rate (2015-2020)
Figure 64. Global Physical Treatment Revenue Growth Rate (2015-2020)
Figure 65. Global Topical Combination Therapy Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Acne Vulgaris Revenue Share by Application (2015-2020)
Figure 68. Global Acne Vulgaris Revenue Share by Application in 2019
Figure 69. Global Acne Vulgaris Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Acne Vulgaris Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Acne Vulgaris Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Acne Vulgaris Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Acne Vulgaris Revenue Market Forecast (2021-2025)
Figure 76. Europe Acne Vulgaris Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Acne Vulgaris Revenue Market Forecast (2021-2025)
Figure 78. South America Acne Vulgaris Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Acne Vulgaris Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel